Sheridan Capital Partners Acquires Carolina Components Group to Accelerate Growth in Biopharmaceutical Solutions
Acquiring Company
Sheridan Capital Partners
Acquired Company
Carolina Components Group
Description
Sheridan Capital Partners has acquired Carolina Components Group, enhancing their capabilities in providing custom solutions for biopharmaceutical manufacturing. The partnership aims to leverage Sheridan's operational resources to support CCG's growth in the market.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Carolina Components Group?
Carolina Components Group was acquired by Sheridan Capital Partners, based in Chicago. The deal was reported on August 7, 2026. Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan Capital Partners is privately held.
When did Sheridan Capital Partners acquire Carolina Components Group?
Sheridan Capital Partners's acquisition of Carolina Components Group was reported on August 7, 2026. Sheridan Capital Partners has acquired Carolina Components Group, enhancing their capabilities in providing custom solutions for biopharmaceutical manufacturing. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Carolina Components Group do?
Carolina Components Group (CCG) manufactures single-use assemblies and components for the biopharmaceutical industry. Established in 2020 and headquartered in Durham, North Carolina, CCG specializes in fluid-handling hardware for biologic drugs. It is privately held, operating in Manufacturing, and is based in Durham.